Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase NA 1

Status

Completed 5Unknown 1Terminated 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5

Conditions

Lymphoma, T-Cell, Cutaneous 8Mycosis Fungoides 7Sezary Syndrome 5Carcinoma, Non-Small-Cell Lung 5Lymphoma 3Leukemia, Myeloid, Acute 3Lymphoma, Primary Cutaneous Anaplastic Large Cell 2Lung Neoplasms 2Leukemia 2Carcinoma 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Sarcoma, Kaposi 1Recurrence 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1HIV Infections 1Congenital Abnormalities 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Anemia, Refractory, with Excess of Blasts 1Aggression 1Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus) 1

Interventions

Carboplatin 341Paclitaxel 262Cisplatin 233Pemetrexed 226Docetaxel 206Erlotinib Hydrochloride 193Gemcitabine 178pembrolizumab 137Bevacizumab 121Radiotherapy 118Nivolumab 84Gefitinib 73Vinorelbine 64Cetuximab 58atezolizumab 47Afatinib 46durvalumab 44osimertinib 41Radiosurgery 35Ipilimumab 34Drug Therapy 32Taxes 30Albumin-Bound Paclitaxel 29130-nm albumin-bound paclitaxel 29Surgical Procedures, Operative 28Etoposide 25Irinotecan 24Sorafenib 21Cyclophosphamide 20Radiation 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Carcinoma, Non-Small-Cell Lung × Bexarotene × Clear all
NCT00411632 2020-01-29

BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

M.D. Anderson Cancer Center

Phase 2 Completed
37 enrolled 9 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00125359 2019-01-08

Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer

Dartmouth-Hitchcock Medical Center

Phase 2 Completed
42 enrolled 10 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT00125372 2019-01-08

Study of Tarceva and Targretin in Stage I-II Lung Cancer

Dartmouth-Hitchcock Medical Center

Phase NA Completed
12 enrolled 10 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT00050973 2013-05-14

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

Eisai Inc.

Phase 3 Completed
623 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00050960 2012-07-13

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

Eisai Inc.

Phase 3 Completed
612 enrolled 10 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡